Phospholipase A2-susceptible liposomes of anticancer double lipid-prodrugs
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference90 articles.
1. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs;Andresen;J. Med. Chem.,2004
2. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release;Andresen;Prog. Lipid Res.,2005
3. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2;Andresen;Curr. Drug Deliv.,2005
4. Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue;Andresen;J. Med. Chem.,2005
5. Enzyme-triggered nanomedicine: drug release strategies in cancer therapy;Andresen;Mol. Membr. Biol.,2010
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enzyme-responsive liposomes for controlled drug release;Drug Discovery Today;2024-07
2. Lipid nanoparticles loaded with anticancer bioactives: state of the art;Cancer Therapy;2024
3. Innovations in liposomal drug delivery: paving the way for personalized cancer therapy;Advanced Drug Delivery Systems for Colonic Disorders;2024
4. Hydroxychloroquine: Key therapeutic advances and emerging nanotechnological landscape for cancer mitigation;Chemico-Biological Interactions;2023-12
5. Recent progress of nanomedicine in secreted phospholipase A2 as a potential therapeutic target;Journal of Materials Chemistry B;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3